Our panel of experts in Hong Kong look at how empowering staff through technology is the name of the game since Covid, the accelerating trend towards ESG investment and the major developments in regulation. Chaired by Romil Patel.
Our panel of experts in Hong Kong look at how empowering staff through technology is the name of the game since Covid, the accelerating trend towards ESG investment and the major developments in regulation. Chaired by Romil Patel.
Our panel of experts at Funds Europe’s London roundtable – held online on October 27 – look at how the asset management industry is adapting to life after Covid-19 as the world struggles to come to terms with the pandemic.
Michael Johnson, group head of institutional services at fund administrator Crestbridge, talks to Funds Europe about the role investors play in the development of the biotech industry.
The majority of family offices will not significantly alter their asset allocation strategies in 2021 despite the likely market turbulence and challenging economic conditions that lie ahead.
Biotechnology – in the spotlight thanks to Covid-19 – surpasses even digital in terms of its scope to transform this century. Much of its funding comes from private equity, where investors face ethical as well as financial dilemmas. Alex Rolandi reports.
FundTech talks to Amundi Services’ Romain Sauvage and Gianluca Minieri about an increased demand for outsourced dealing among fund managers, driven by rising technology costs and the impact of Covid-19.
